NCT07373496 Patient Position Monitoring System for Beam Gated Radiation Therapy of Malignancies of the Chest and Upper Abdomen
| NCT ID | NCT07373496 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Washington University School of Medicine |
| Condition | Radiotherapy |
| Study Type | OBSERVATIONAL |
| Enrollment | 20 participants |
| Start Date | 2026-05-20 |
| Primary Completion | 2027-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 20 participants in total. It began in 2026-05-20 with a primary completion date of 2027-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will evaluate the feasibility of using this novel patient position monitoring system for patients receiving radiation therapy to targets involving the chest or upper abdomen, as these are the most affected by respiratory motion. This motion monitoring system will be incorporated with standard of care on-board CT imaging to confirm that the respiratory position is tracking the tumor target appropriately.
Eligibility Criteria
Eligibility Criteria * Planning to receive a course of radiation therapy that, per the treating radiation oncologist, requires motion management at the time of CT simulation and during treatment. Types of treatments that require motion management during radiation therapy include treatments to the lung, heart, breast, and upper abdomen (pancreas, liver, adrenals). These may include either free-breathing treatments or breath-hold treatments. * At least 18 years of age. * No documented allergy to medical grade adhesives. * Able to understand and willing to sign an IRB approved written informed consent document.
Contact & Investigator
Pamela Samson, MD, MPHS
PRINCIPAL INVESTIGATOR
Washington University School of Medicine
Frequently Asked Questions
Who can join the NCT07373496 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Radiotherapy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07373496 currently recruiting?
Yes, NCT07373496 is actively recruiting participants. Contact the research team at psamson@wustl.edu for enrollment information.
Where is the NCT07373496 trial being conducted?
This trial is being conducted at St Louis, United States.
Who is sponsoring the NCT07373496 clinical trial?
NCT07373496 is sponsored by Washington University School of Medicine. The principal investigator is Pamela Samson, MD, MPHS at Washington University School of Medicine. The trial plans to enroll 20 participants.